| Year |
Citation |
Score |
| 2020 |
Vala C, Mothes C, Chicheri G, Magadur P, Viot G, Deloye JB, Maia S, Bouvet Y, Dupont AC, Arlicot N, Guilloteau D, Emond P, Vercouillie J. Fully automated radiosynthesis of [F]LBT999 on TRACERlab FX and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain. Ejnmmi Radiopharmacy and Chemistry. 5: 26. PMID 33196944 DOI: 10.1186/s41181-020-00105-w |
0.536 |
|
| 2020 |
Ribeiro MJ, Vercouillie J, Arlicot N, Tauber C, Gissot V, Mondon K, Barantin L, Cottier JP, Maia S, Deloye JB, Emond P, Guilloteau D. Usefulness of PET With [F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment. Frontiers in Neurology. 11: 754. PMID 32973645 DOI: 10.3389/fneur.2020.00754 |
0.564 |
|
| 2020 |
Ribeiro M, Vercouillie J, Arlicot N, Tauber C, Gissot V, Mondon K, Barantin L, Cottier J, Maia S, Deloye J, Emond P, Guilloteau D. Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment Frontiers in Neurology. 11. DOI: 10.3389/Fneur.2020.00754 |
0.604 |
|
| 2019 |
Beaurain M, Salabert AS, Ribeiro MJ, Arlicot N, Damier P, Le Jeune F, Demonet JF, Payoux P. Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience. Frontiers in Medicine. 6: 268. PMID 31828073 DOI: 10.3389/Fmed.2019.00268 |
0.429 |
|
| 2019 |
Desmidt T, Delrieu J, Lebouvier T, Robert G, David R, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MJ, Payoux P, Vellas B, El-Hage W, Tavernier E, Camus V, et al. Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort. Neurobiology of Aging. 84: 61-69. PMID 31514054 DOI: 10.1016/J.Neurobiolaging.2019.08.008 |
0.315 |
|
| 2019 |
Arlicot N, Vercouillie J, Malherbe C, Bidault R, Gissot V, Maia S, Barantin L, Cottier JP, Deloye JB, Guilloteau D, Ribeiro MJ. PET imaging of Dopamine Transporter with [18F]LBT-999: initial evaluation in healthy volunteers. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 31496203 DOI: 10.23736/S1824-4785.19.03175-3 |
0.563 |
|
| 2019 |
Bodet-Milin C, Bailly C, Touchefeu Y, Frampas E, Bourgeois M, Rauscher A, Lacoeuille F, Drui D, Arlicot N, Goldenberg DM, Faivre-Chauvet A, Barbet J, Rousseau C, Kraeber-Bodéré F. Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches. Frontiers in Medicine. 6: 124. PMID 31214593 DOI: 10.3389/Fmed.2019.00124 |
0.378 |
|
| 2019 |
Chalon S, Vercouillie J, Payoux P, Deloye JB, Malherbe C, Le Jeune F, Arlicot N, Salabert AS, Guilloteau D, Emond P, Ribeiro MJ. The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use. Frontiers in Medicine. 6: 90. PMID 31131278 DOI: 10.3389/Fmed.2019.00090 |
0.611 |
|
| 2019 |
Elie J, Vercouillie J, Arlicot N, Lemaire L, Bidault R, Bodard S, Hosselet C, Deloye JB, Chalon S, Emond P, Guilloteau D, Buron F, Routier S. Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [F] PET tracer. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 1-7. PMID 30362376 DOI: 10.1080/14756366.2018.1501043 |
0.562 |
|
| 2019 |
Malherbe C, Bidault R, Netter C, Guilloteau D, Vercouillie J, Arlicot N. Development of a Fast and Facile Analytical Approach to Quantify Radiometabolites in Human Plasma Samples Using Ultra High Performance Liquid Chromatography American Journal of Analytical Chemistry. 10: 185-201. DOI: 10.4236/Ajac.2019.105016 |
0.535 |
|
| 2018 |
Dupont AC, Largeau B, Guilloteau D, Santiago Ribeiro MJ, Arlicot N. The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases. Contrast Media & Molecular Imaging. 2018: 7043578. PMID 29887768 DOI: 10.1155/2018/7043578 |
0.611 |
|
| 2018 |
Ribeiro MS, Vercouillie J, Gissot V, Maia S, Barantin L, Peltier Y, Cottier J, Deloye J, Arlicot N, Guilloteau D. Le 18F-LBT-999, le nouveau traceur TEP du DAT ? MéDecine NucléAire. 42: 137-138. DOI: 10.1016/J.Mednuc.2018.03.017 |
0.555 |
|
| 2017 |
Largeau B, Dupont AC, Guilloteau D, Santiago-Ribeiro MJ, Arlicot N. TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases? Contrast Media & Molecular Imaging. 2017: 6592139. PMID 29114179 DOI: 10.1155/2017/6592139 |
0.618 |
|
| 2017 |
Malherbe C, Dupont AC, Maia S, Venel Y, Erra B, Santiago-Ribeiro MJ, Arlicot N. Estimation of the added value of 99mTc-HMPAO labelled white blood cells scintigraphy for the diagnosis of infectious foci. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 28478665 DOI: 10.23736/S1824-4785.17.02964-8 |
0.365 |
|
| 2017 |
Tronel C, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Dupont AC, Arlicot N. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations. International Journal of Molecular Sciences. 18. PMID 28398245 DOI: 10.3390/Ijms18040802 |
0.611 |
|
| 2017 |
Dupont AC, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Tronel C, Arlicot N. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. International Journal of Molecular Sciences. 18. PMID 28387722 DOI: 10.3390/Ijms18040785 |
0.634 |
|
| 2017 |
Dupont A, Malherbe C, Berry O, Venel Y, Santiago Ribeiro M, Arlicot N, Maia S. Impact médico-économique de la surveillance des prescriptions de TEP-18F-FDG MéDecine NucléAire. 41: 185. DOI: 10.1016/J.Mednuc.2017.02.126 |
0.364 |
|
| 2017 |
Malherbe C, Ligonie A, Dupont A, Courtehoux M, Venel Y, Santiago Ribeiro M, Arlicot N, Maia S. Intérêt diagnostique de la scintigraphie des récepteurs à la somatostatine à l’111Indium-pentetréotide (Octréoscan ® ) : étude rétrospective au CHRU de Tours MéDecine NucléAire. 41: 184. DOI: 10.1016/J.Mednuc.2017.02.124 |
0.305 |
|
| 2017 |
Santiago Ribeiro M, Vercouillie J, Maia S, Gissot V, Bonnet Brilhault F, Guilloteau D, Arlicot N. Cinétique cérébrale du [18F]-FPEB, radioligand spécifique du mGluR5, chez le volontaire sain MéDecine NucléAire. 41: 168-169. DOI: 10.1016/J.Mednuc.2017.02.080 |
0.546 |
|
| 2017 |
Dupont A-, Ribeiro M-S, Guilloteau D, Arlicot N. β-amyloid PET neuroimaging: A review of radiopharmaceutical development Medecine Nucleaire-Imagerie Fonctionnelle Et Metabolique. 41: 27-35. DOI: 10.1016/J.Mednuc.2016.12.002 |
0.368 |
|
| 2016 |
Barbet J, Arlicot N, Gaugler MH, Chérel M, Guilloteau D, Kraeber-Bodéré F. Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology. Frontiers in Medicine. 3: 74. PMID 28123998 DOI: 10.3389/Fmed.2016.00074 |
0.541 |
|
| 2016 |
Dupont AC, Guilloteau D, Kassiou M, Ribeiro MJ, Vercouillie J, Katsifis A, Arlicot N. Radiopharmaceuticals for PET imaging of neuroinflammation Medecine Nucleaire. 40: 72-81. DOI: 10.1016/J.Mednuc.2016.01.001 |
0.61 |
|
| 2015 |
Dupont A, Guilloteau D, Ben-Azzouna R, Bidault R, Algalarrondo V, Slama M, Arlicot N, Le Guludec D. [18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study Orphanet Journal of Rare Diseases. 10. DOI: 10.1186/1750-1172-10-S1-P38 |
0.55 |
|
| 2015 |
Santiago-Ribeiro M, Vercouillie J, Cottier J, Debiais S, Bonnaud I, Annan M, Maia S, Kassiou M, Arlicot N, Guilloteau D. Évaluation en TEP de l’activation microgliale après un accident vasculaire cérébral MéDecine NucléAire. 39: 210. DOI: 10.1016/J.Mednuc.2015.03.015 |
0.337 |
|
| 2014 |
Arlicot N, Tronel C, Bodard S, Garreau L, de la Crompe B, Vandevelde I, Guilloteau D, Antier D, Chalon S. Translocator Protein (18 kDa) Mapping with [(125)I]-CLINDE in the Quinolinic Acid Rat Model of Excitotoxicity: A Longitudinal Comparison with Microglial Activation, Astrogliosis, and Neuronal Death. Molecular Imaging. 13: 7290201300075. PMID 28650286 DOI: 10.2310/7290.2013.00075 |
0.505 |
|
| 2014 |
Ribeiro MJ, Vercouillie J, Debiais S, Cottier JP, Bonnaud I, Camus V, Banister S, Kassiou M, Arlicot N, Guilloteau D. Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period? Ejnmmi Research. 4: 28. PMID 25006546 DOI: 10.1186/S13550-014-0028-4 |
0.578 |
|
| 2014 |
Arlicot N, Tronel C, Bodard S, Garreau L, de la Crompe B, Vandevelde I, Guilloteau D, Antier D, Chalon S. Translocator protein (18 kDa) mapping with [125I]-CLINDE in the quinolinic acid rat model of excitotoxicity: a longitudinal comparison with microglial activation, astrogliosis, and neuronal death. Molecular Imaging. 13: 4-11. PMID 24622813 DOI: 10.2310/7290.2013.00075 |
0.551 |
|
| 2014 |
Hommet C, Mondon K, Camus V, Ribeiro MJ, Beaufils E, Arlicot N, Corcia P, Paccalin M, Minier F, Gosselin T, Page G, Guilloteau D, Chalon S. Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging. Dementia and Geriatric Cognitive Disorders. 37: 1-18. PMID 24107621 DOI: 10.1159/000354363 |
0.556 |
|
| 2013 |
Martins AF, Morfin JF, Kubí?ková A, Kubí?ek V, Buron F, Suzenet F, Salerno M, Lazar AN, Duyckaerts C, Arlicot N, Guilloteau D, Geraldes CF, Tóth E. PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques. Acs Medicinal Chemistry Letters. 4: 436-40. PMID 24900692 DOI: 10.1021/Ml400042W |
0.54 |
|
| 2013 |
Petitcollin A, Maia S, Guilloteau D, Dupuis S, Arlicot N. Développement d’une méthode rapide de chromatographie sur couche mince pour le contrôle qualité du 99mTc-HMPAO en routine MéDecine NucléAire. 37: 171. DOI: 10.1016/J.Mednuc.2013.03.137 |
0.522 |
|
| 2013 |
Santiago-Ribeiro M, Vercouillie J, Corcia P, Arlicot N, Erra B, Maia S, Bonnaud I, Debiais S, Kassiou M, Guilloteau D. Distribution cérébrale du 18F-DPA-714 et neuro-inflammation aiguë et chronique MéDecine NucléAire. 37: 141-142. DOI: 10.1016/J.Mednuc.2013.03.025 |
0.551 |
|
| 2013 |
Erra B, Vercouillie J, Corcia P, Maïa S, Arlicot N, Baulieu J, Guilloteau D, Santiago Ribeiro M. Distribution physiologique cérébrale et corps entier du 18F-DPA-714 en TEP/TDM MéDecine NucléAire. 37: 44-51. DOI: 10.1016/J.Mednuc.2013.01.004 |
0.572 |
|
| 2012 |
Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, Cottier JP, Roussel C, Kassiou M, Guilloteau D, Ribeiro MJ. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. Plos One. 7: e52941. PMID 23300829 DOI: 10.1371/Journal.Pone.0052941 |
0.588 |
|
| 2012 |
Maia S, Arlicot N, Vierron E, Bodard S, Vergote J, Guilloteau D, Chalon S. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. Synapse (New York, N.Y.). 66: 573-83. PMID 22337286 DOI: 10.1002/Syn.21543 |
0.543 |
|
| 2012 |
Arlicot N, Vercouillie J, Ribeiro MJ, Tauber C, Venel Y, Baulieu JL, Maia S, Corcia P, Stabin MG, Reynolds A, Kassiou M, Guilloteau D. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Nuclear Medicine and Biology. 39: 570-8. PMID 22172392 DOI: 10.1016/J.Nucmedbio.2011.10.012 |
0.623 |
|
| 2012 |
Arlicot N, Chalon S, Vercouillie J, Bodard S, Serrière S, Ribeiro M, Baulieu J, Stabin M, Kassiou M, Guilloteau D. Estimation de la dosimétrie chez l’homme du [18F]Dpa-714, un radiopharmaceutique pour l’imagerie TEP de la neuroinflammation MéDecine NucléAire. 36: 169. DOI: 10.1016/J.Mednuc.2012.02.040 |
0.338 |
|
| 2012 |
Santiago-Ribeiro M, Vercouille J, Tauber C, Venel Y, Baulieu J, Maia S, Arlicot N, Corcia P, Kassiou M, Guilloteau D. Cinétique cérébrale du [18F]DPA-714 en tomographie par émission de positons chez le volontaire sain MéDecine NucléAire. 36: 169. DOI: 10.1016/J.Mednuc.2012.02.039 |
0.583 |
|
| 2012 |
Duval S, Siñeriz F, Arlicot N, Barbier-Chassefire V, Vercouillie J, Delbé J, Papy-Garcia D, Guilloteau D, Barritault D. Development of radiotracers for the molecular imaging of tumor matrix microenvironment (HIMIMT) | Développement de radiotraceurs pour l'imagerie moléculaire du microenvironnement matriciel tumoral (HIMIMT) Irbm. 33: 86-91. DOI: 10.1016/J.Irbm.2012.01.006 |
0.5 |
|
| 2010 |
Arlicot N, Petit E, Katsifis A, Toutain J, Divoux D, Bodard S, Roussel S, Guilloteau D, Bernaudin M, Chalon S. Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. European Journal of Nuclear Medicine and Molecular Imaging. 37: 2371-80. PMID 20814674 DOI: 10.1007/S00259-010-1598-7 |
0.567 |
|
| 2010 |
Song PJ, Barc C, Arlicot N, Guilloteau D, Bernard S, Sarradin P, Chalon S, Garreau L, Kung HF, Lantier F, Vergote J. Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 12: 576-82. PMID 20376566 DOI: 10.1007/S11307-010-0321-1 |
0.568 |
|
| 2008 |
Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, Kousignian I, Bodard S, Guilloteau D, Chalon S. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. European Journal of Nuclear Medicine and Molecular Imaging. 35: 2203-11. PMID 18536913 DOI: 10.1007/S00259-008-0834-X |
0.726 |
|
| 2008 |
Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, Kousignian I, Bodard S, Guilloteau D, Chalon S. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation (European Journal of Nuclear Medicine and Molecular Imaging DOI: 10.1007/s00259-008-0834-x) European Journal of Nuclear Medicine and Molecular Imaging. 35: 2341. DOI: 10.1007/s00259-008-0882-2 |
0.734 |
|
| Show low-probability matches. |